The recent dramatic progress in the application of diffraction and spectroscopic techniques of structural biology has provided high resolution structural information on many individual proteins and their complexes. In cases where such proteins form biological polymers, this information provides a firm basis for consideration of structural factors affecting supramolecular assembly. However information from additional sources and techniques is frequently necessary in defining the mechanisms of the assembly process. In this article, structural and kinetic evidence on the assembly of microtubules and the formation of amyloid fibrils is presented, and compared as examples of two biophysical processes with contrasting biological roles with respect to cellular health and survival.
Keywords: amyloids, dynamic instability, oligomers, prion protein, protofilaments, tubulin
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aguzzi, A. (2004) Understanding the diversity of prions. Nat. Cell. Biol. 6: 290-2.
Apetri, A.C., Vanik, D.L. and Surewicz, W.K. (2005) Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231. Biochemistry 44: 15880-8.
Ban, T., Hamada, D., Hasegawa, K., Naiki, H. and Goto, Y. (2003) Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J. Biol. Chem. 278: 16462-5.
Ban, T., Hoshino, M., Takahashi, S., Hamada, D., Hasegawa, K., Naiki, H. and Goto, Y. (2004) Direct observation of abeta amyloid fibril growth and inhibition. J. Mol. Biol. 344: 757-67.
Baskakov, I.V. and Bocharova, O.V. (2005) In vitro conversion of Mammalian prion protein into amyloid fibrils displays unusual features. Biochemistry 44: 2339-48.
Bocharova, O.V., Breydo, L., Parfenov, A.S., Salnikov, V.V. and Baskakov, I.V. (2005) In vitro Conversion of Full-length Mammalian Prion Protein Produces Amyloid Form with Physical Properties of PrP(Sc). J. Mol. Biol. 346: 645-59.
Boshuizen, R.S., Langeveld, J.P., Salmona, M., Williams, A., Meloen, R.H. and Langedijk, J.P. (2004) An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds. Anal. Biochem. 333: 372-80.
Breydo, L., Bocharova, O.V. and Baskakov, I.V. (2005) Semiautomated cell-free conversion of prion protein: Applications for high-throughput screening of potential antiprion drugs. Anal. Biochem. 339: 165-73.
Buey, R.M., Barasoain, I., Jackson, E., Meyer, A., Giannakakou, P., Paterson, I., Mooberry, S., Andreu, J.M. and Diaz, J.F. (2005) Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity. Chem. Biol. 12: 1269-79.
Calzolai, L. and Zahn, R. (2003) Influence of pH on NMR structure and stability of the human prion protein globular domain. J. Biol. Chem. 278: 35592-6.
Carvalho, P., Tirnauer, J.S. and Pellman, D. (2003) Surfing on microtubule ends. Trends Cell Biol. 13: 229-37.
Cashman, N.R. and Caughey, B. (2004) Prion diseases - close to effective therapy? Nat. Rev. Drug Discov. 3: 874-84.
Caughey, B. and Baron, G.S. (2006) Prions and their partners in crime. Nature 443: 803-10.
Caughey, B., Caughey, W.S., Kocisko, D.A., Lee, K.S., Silveira, J.R. and Morrey, J.D. (2006) Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds? Acc. Chem. Res. 39: 646-53.
Chen, Y.D. and Hill, T.L. (1985) Monte Carlo study of the GTP cap in a five-start helix model of a microtubule. Proc. Natl. Acad. Sci. USA 82: 1131-5.
Cunningham, C., Deacon, R., Wells, H., Boche, D., Waters, S., Diniz, C. P., Scott, H., Rawlins, J.N. and Perry, V.H. (2003) Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur. J. Neurosci. 17: 2147-55.
Dimcheff, D.E., Portis, J.L. and Caughey, B. (2003) Prion proteins meet protein quality control. Trends Cell Biol. 13: 337-40.
Dobson, C.M. (2001) The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356: 133-45.
Ferguson, N., Becker, J., Tidow, H., Tremmel, S., Sharpe, T.D., Krause, G., Flinders, J., Petrovich, M., Berriman, J., Oschkinat, H. et al. (2006) General structural motifs of amyloid protofilaments. Proc. Natl. Acad. Sci. USA 103: 16248-53.
Goldsbury, C., Frey, P., Olivieri, V., Aebi, U. and Muller, S.A. (2005) Multiple assembly pathways underlie amyloid-beta fibril polymorphisms. J. Mol. Biol. 352: 282-98.
Govaerts, C., Wille, H., Prusiner, S.B. and Cohen, F.E. (2004) Evidence for assembly of prions with left-handed beta-helices into trimers. Proc. Natl. Acad. Sci. USA 101: 8342-7.
Griffith, J.S. (1967) Self-replication and scrapie. Nature 215: 1043-4.
Haire, L.F., Whyte, S.M., Vasisht, N., Gill, A.C., Verma, C., Dodson, E.J., Dodson, G.G. and Bayley, P.M. (2004) The crystal structure of the globular domain of sheep prion protein. J. Mol. Biol. 336: 1175-83.
Ionescu-Zanetti, C., Khurana, R., Gillespie, J.R., Petrick, J.S., Trabachino, L.C., Minert, L.J., Carter, S.A. and Fink, A.L. (1999) Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy. Proc. Natl. Acad. Sci. USA 96: 13175-9.
Jamin, N., Coic, Y.M., Landon, C., Ovtracht, L., Baleux, F., Neumann, J.M. and Sanson, A. (2002) Most of the structural elements of the globular domain of murine prion protein form fibrils with predominant beta-sheet structure. FEBS Lett. 529: 256-60.
Janosi, I.M., Chretien, D. and Flyvbjerg, H. (2002) Structural microtubule cap: stability, catastrophe, rescue, and third state. Biophys. J. 83: 1317-30.
Kelly, J.W. (1996) Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6: 11-7.
Kirschner, M. and Mitchison, T. (1986) Beyond self-assembly: from microtubules to morphogenesis. Cell 45: 329-42.
Knaus, K.J., Morillas, M., Swietnicki, W., Malone, M., Surewicz, W.K. and Yee, V.C. (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8: 770-4.
Legname, G., Nguyen, H.O., Baskakov, I.V., Cohen, F.E., Dearmond, S.J. and Prusiner, S.B. (2005) Strain-specified characteristics of mouse synthetic prions. Proc. Natl. Acad. Sci. USA.
Luhrs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Dobeli, H., Schubert, D. and Riek, R. (2005) 3D structure of Alzheimer’s amyloid-beta(1-42) fibrils. Proc. Natl. Acad. Sci. USA 102: 17342-7.
Ma, J., Wollmann, R. and Lindquist, S. (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298: 1781-5.
Makin, O.S., Atkins, E., Sikorski, P., Johansson, J. and Serpell, L.C. (2005) Molecular basis for amyloid fibril formation and stability. Proc. Natl. Acad. Sci. USA 102: 315-20.
Makin, O.S. and Serpell, L.C. (2005) Structures for amyloid fibrils. FEBS J. 272: 5950-61.
Martin, S.R., Schilstra, M.J. and Bayley, P.M. (1993) Dynamic instability of microtubules: Monte Carlo simulation and application to different types of microtubule lattice. Biophys. J. 65: 578-96.
McKinley, M.P., Meyer, R.K., Kenaga, L., Rahbar, F., Cotter, R., Serban, A. and Prusiner, S.B. (1991) Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J. Virol. 65: 1340-51.
Mitchison, T. and Kirschner, M. (1984) Dynamic instability of microtubule growth. Nature 312: 237-42.
Nelson, R., Sawaya, M.R., Balbirnie, M., Madsen, A.O., Riekel, C., Grothe, R. and Eisenberg, D. (2005) Structure of the cross-beta spine of amyloid-like fibrils. Nature 435: 773-8.
Nogales, E. and Wang, H.W. (2006a) Structural mechanisms underlying nucleotide-dependent self-assembly of tubulin and its relatives. Curr. Opin. Struct. Biol. 16: 221-9.
Nogales, E. and Wang, H.W. (2006b) Structural intermediates in microtubule assembly and disassembly: how and why? Curr. Opin. Cell. Biol. 18: 179-84.
Nunziante, M., Gilch, S. and Schatzl, H.M. (2003) Prion diseases: from molecular biology to intervention strategies. Chembiochem. 4: 1268-84.
Okura, Y., Miyakoshi, A., Kohyama, K., Park, I.K., Staufenbiel, M. and Matsumoto, Y. (2006) Nonviral A{beta} DNA vaccine therapy against Alzheimer’s disease: Long-term effects and safety. Proc. Natl. Acad. Sci. USA. 103: 9619-24.
Oosawa, F. and Asakura, S. (1975) Thermodynamics of the polymerization of proteins. Academic Press, London.
Petkova, A.T., Buntkowsky, G., Dyda, F., Leapman, R.D., Yau, W.M. and Tycko, R. (2004) Solid state NMR reveals a pH-dependent antiparallel beta-sheet registry in fibrils formed by a beta-amyloid peptide. J. Mol. Biol. 335: 247-60.
Petkova, A.T., Yau, W.M. and Tycko, R. (2006) Experimental constraints on quaternary structure in Alzheimer’s beta-amyloid fibrils. Biochemistry 45: 498-512.
Prusiner, S.B. (1993) Transgenetic investigations of prion diseases of humans and animals. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 339: 239-54.
Prusiner, S.B. (1998) Prions. Proc. Natl. Acad. Sci. USA 95: 13363-83.
Rezaei, H., Eghiaian, F., Perez, J., Doublet, B., Choiset, Y., Haertle, T. and Grosclaude, J. (2005) Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities. J. Mol. Biol. 347: 665-79.
Serpell, L.C., Blake, C.C. and Fraser, P.E. (2000a) Molecular structure of a fibrillar Alzheimer’s A beta fragment. Biochemistry 39: 13269-75.
Serpell, L.C., Sunde, M., Benson, M.D., Tennent, G.A., Pepys, M.B. and Fraser, P.E. (2000b) The protofilament substructure of amyloid fibrils. J. Mol. Biol. 300: 1033-9.
Silveira, J.R., Raymond, G.J., Hughson, A.G., Race, R.E., Sim, V.L., Hayes, S.F. and Caughey, B. (2005) The most infectious prion protein particles. Nature 437: 257-61.
Souillac, P.O., Uversky, V.N. and Fink, A.L. (2003) Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN. Biochemistry 42: 8094-104.
Stolz, M., Stoffler, D., Aebi, U. and Goldsbury, C. (2000) Monitoring biomolecular interactions by time-lapse atomic force microscopy. J. Struct. Biol. 131: 171-80.
Supattapone, S., Bosque, P., Muramoto, T., Wille, H., Aagaard, C., Peretz, D., Nguyen, H.O., Heinrich, C., Torchia, M., Safar, J. et al. (1999) Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice. Cell 96: 869-78.
Tanaka, M., Collins, S.R., Toyama, B.H. and Weissman, J.S. (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442: 585-9.
Tattum, M.H., Cohen-Krausz, S., Khalili-Shirazi, A., Jackson, G.S., Orlova, E.V., Collinge, J., Clarke, A.R. and Saibil, H.R. (2006) Elongated oligomers assemble into mammalian PrP amyloid fibrils. J. Mol. Biol. 357: 975-85.
Tuite, M.F. and Cox, B.S. (2006) The [PSI+] prion of yeast: a problem of inheritance. Methods 39: 9-22.
Watzlawik, J., Skora, L., Frense, D., Griesinger, C., Zweckstetter, M., Schulz-Schaeffer, W.J. and Kramer, M.L. (2006) Prion protein Helix1 promotes aggregation but is not converted into beta-sheet. J. Biol. Chem. 281: 30242-50.
Weissmann, C. (1999) Molecular genetics of transmissible spongiform encephalopathies. J. Biol. Chem. 274: 3-6.
Weissmann, C. (2005) Birth of a prion: spontaneous generation revisited. Cell 122: 165-8.
Welker, E., Raymond, L.D., Scheraga, H.A. and Caughey, B. (2002) Intramolecular versus intermolecular disulfide bonds in prion proteins. J. Biol. Chem. 277: 33477-81.
Westermark, P. (2005) Aspects on human amyloid forms and their fibril polypeptides. FEBS J. 272: 5942-9.
Westermark, P., Engstrom, U., Johnson, K.H., Westermark, G.T. and Betsholtz, C. (1990) Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc. Natl. Acad. Sci. USA 87: 5036-40.
Wickner, R.B., Edskes, H.K., Ross, E.D., Pierce, M.M., Baxa, U., Brachmann, A. and Shewmaker, F. (2004) Prion genetics: new rules for a new kind of gene. Annu. Rev. Genet. 38: 681-707.
Wille, H., Michelitsch, M.D., Guenebaut, V., Supattapone, S., Serban, A., Cohen, F.E., Agard, D.A. and Prusiner, S.B. (2002) Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl. Acad. Sci. USA 99: 3563-8.
Wu, X., Xiang, X. and Hammer, J.A., 3rd. (2006) Motor proteins at the microtubule plus-end. Trends Cell Biol. 16: 135-43.
Wuthrich, K. and Riek, R. (2001) Three-dimensional structures of prion proteins. Adv. Protein Chem. 57: 55-82.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Bayley, P. (2007). Mechanisms of Supramolecular Assembly Exemplified by Microtubules and Amyloid Fibril Formation. In: Pifat-Mrzljak, G. (eds) Supramolecular Structure and Function 9. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6466-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6466-1_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6465-4
Online ISBN: 978-1-4020-6466-1
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)